Mass General/North Shore Cancer — Peabody, Massachusetts

Mass General/North Shore Cancer is a clinical research site located in Peabody, Massachusetts, United States 01960.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Mass General/North Shore Cancer has participated in 1 clinical trials.

Therapeutic areas: Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General/North Shore Cancer?

Mass General/North Shore Cancer has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General/North Shore Cancer conducted?

Mass General/North Shore Cancer has 1 clinical trials on record. Their work covers Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer.

Is Mass General/North Shore Cancer accredited by Crixeo Health?

Mass General/North Shore Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass General/North Shore Cancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.